BP1210

Ritonavir

British Pharmacopoeia (BP) Reference Standard

• Synonym(e): 1,3-Thiazol-5-ylmethyl-N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)-methyl]-carbamoyl]-amino]-butanoyl]-amino]-1,6-diphenylhexan-2-yl]-carbamat
• Empirische Formel (Hill-System): C₃₇H₄₈N₆O₅S₂
• CAS-Nummer: 155213-67-5
• Molekulargewicht: 720.94
• UNSPSC-Code: 41116107
• NACRES: NA.24

Eigenschaften

• Qualität: pharmaceutical primary standard
• Qualitätsniveau: 100
• Agentur: BP
• API-Familie: ritonavir
• Form: solid
• Haltbarkeit: limited shelf life, expiry date on the label
• Verpackung: pkg of 100 mg
• Hersteller/Markenname: BP
• Lagerbedingungen: dry at room temperature
• Farbe: off-white
• mp (Schmelzpunkt): 122-126 °C
• Löslichkeit: ethanol: soluble; isopropanol: soluble; methanol: soluble
• Dichte: 1.239 g/cm³ at 20 °C
• Anwendung(en): pharmaceutical; pharmaceutical small molecule
• Format: neat
• Versandbedingung: ambient
• Lagertemp.: 2-8°C
• InChI: 1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1
• InChIKey: NCDNCNXCDXHOMX-XGKFQTDJSA-N

Beschreibung

Allgemeine Beschreibung

Ritonavir belongs to the group of protease inhibitors that are widely used in combination with other drugs in the prevention of HIV. Its mode of action involves binding to the active site of the protease enzyme and preventing the further maturation of new viral particles.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Ritonavir BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Ritonavir Oral Solution

Ritonavir Tablets

Verpackung

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

Sonstige Hinweise

Sales restrictions may apply.

Sicherheitshinweise

• Piktogramme: GHS07
• Signalwort: Warning
• H-Sätze: H302 + H312 + H332
• P-Sätze: P280 - P301 + P312 + P330 - P302 + P352 + P312 - P304 + P340 + P312
• Gefahreneinstufungen: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable